1. Home
  2. MGX vs LOOP Comparison

MGX vs LOOP Comparison

Compare MGX & LOOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGX
  • LOOP
  • Stock Information
  • Founded
  • MGX 2018
  • LOOP 2010
  • Country
  • MGX United States
  • LOOP Canada
  • Employees
  • MGX N/A
  • LOOP N/A
  • Industry
  • MGX
  • LOOP Major Chemicals
  • Sector
  • MGX
  • LOOP Industrials
  • Exchange
  • MGX NYSE
  • LOOP Nasdaq
  • Market Cap
  • MGX 62.1M
  • LOOP 63.9M
  • IPO Year
  • MGX 2024
  • LOOP N/A
  • Fundamental
  • Price
  • MGX $2.17
  • LOOP $1.21
  • Analyst Decision
  • MGX Strong Buy
  • LOOP
  • Analyst Count
  • MGX 4
  • LOOP 0
  • Target Price
  • MGX $13.00
  • LOOP N/A
  • AVG Volume (30 Days)
  • MGX 912.4K
  • LOOP 191.7K
  • Earning Date
  • MGX 08-13-2025
  • LOOP 07-22-2025
  • Dividend Yield
  • MGX N/A
  • LOOP N/A
  • EPS Growth
  • MGX N/A
  • LOOP N/A
  • EPS
  • MGX N/A
  • LOOP N/A
  • Revenue
  • MGX $45,263,000.00
  • LOOP $10,889,000.00
  • Revenue This Year
  • MGX N/A
  • LOOP N/A
  • Revenue Next Year
  • MGX $11.75
  • LOOP $592.45
  • P/E Ratio
  • MGX N/A
  • LOOP N/A
  • Revenue Growth
  • MGX N/A
  • LOOP 7016.99
  • 52 Week Low
  • MGX $1.23
  • LOOP $0.85
  • 52 Week High
  • MGX $5.50
  • LOOP $2.29
  • Technical
  • Relative Strength Index (RSI)
  • MGX 71.83
  • LOOP 43.51
  • Support Level
  • MGX $1.45
  • LOOP $1.05
  • Resistance Level
  • MGX $2.47
  • LOOP $1.25
  • Average True Range (ATR)
  • MGX 0.16
  • LOOP 0.15
  • MACD
  • MGX 0.09
  • LOOP -0.05
  • Stochastic Oscillator
  • MGX 75.47
  • LOOP 27.94

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

Share on Social Networks: